Hepatitis C Elimination: Challenges with Under-diagnosis and Under-treatment

Overview

Journal F1000Res

Specialties Biomedical Engineering
Science

Date 2019 Jan 29

PMID 30687501

Citations 16

Authors

Norah A Terrault

Affiliations

Soon will be listed here.

Abstract

Hepatitis C infection has affected 189 million people globally and more than 4 million in the US. Owing to remarkable advances in the therapeutic sphere, essentially all infected patients can be expected to achieve cure. This provides an unprecedented opportunity to eliminate the risk of complications from hepatitis C and to reduce the spread of the virus to others. To achieve this, a streamlined cascade of care from diagnosis to treatment may be enacted. Although great strides have been made, under-diagnosis and under-treatment remain major hurdles.

Citing Articles

A qualitative investigation of the barriers and facilitators to Hepatitis C virus (HCV) screening among individuals experiencing homelessness in Houston, Texas.

Celeste-Villalvir A, Wilkerson J, Markham C, Rodriguez L, Schick V Dialogues Health. 2024; 1:100058.

PMID: 38515888 PMC: 10953933. DOI: 10.1016/j.dialog.2022.100058.

Engineering highly thermostable Cas12b via de novo structural analyses for one-pot detection of nucleic acids.

Nguyen L, Rananaware S, Yang L, Macaluso N, Ocana-Ortiz J, Meister K Cell Rep Med. 2023; 4(5):101037.

PMID: 37160120 PMC: 10213852. DOI: 10.1016/j.xcrm.2023.101037.

Convergent antibody responses are associated with broad neutralization of hepatitis C virus.

Skinner N, Ogega C, Frumento N, Clark K, Yegnasubramanian S, Schuebel K Front Immunol. 2023; 14:1135841.

PMID: 37033983 PMC: 10080129. DOI: 10.3389/fimmu.2023.1135841.

Laying the foundations for hepatitis C elimination: evaluating the development and contribution of community care pathways to diagnostic efforts.

Robinson E, Byrne C, Carberry J, Radley A, Beer L, Inglis S BMC Public Health. 2023; 23(1):54.

PMID: 36611156 PMC: 9826577. DOI: 10.1186/s12889-022-14911-1.

Finding Cases of Hepatitis C for Treatment Using Automated Screening in the Emergency Department is Effective, but What Is the Cost?.

Prince D, Girolamo J, Pipicella J, Bagatella M, Kayes T, Alvaro F Can J Gastroenterol Hepatol. 2022; 2022:3449938.

PMID: 36276913 PMC: 9586809. DOI: 10.1155/2022/3449938.

References

Perz J, Armstrong G, Farrington L, Hutin Y, Bell B . The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006; 45(4):529-38. DOI: 10.1016/j.jhep.2006.05.013. View

Arora S, Thornton K, Jenkusky S, Parish B, Scaletti J . Project ECHO: linking university specialists with rural and prison-based clinicians to improve care for people with chronic hepatitis C in New Mexico. Public Health Rep. 2007; 122 Suppl 2:74-7. PMC: 1831800. DOI: 10.1177/00333549071220S214. View

Arora S, Thornton K, Murata G, Deming P, Kalishman S, Dion D . Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med. 2011; 364(23):2199-207. PMC: 3820419. DOI: 10.1056/NEJMoa1009370. View

Denniston M, Klevens R, McQuillan G, Jiles R . Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008. Hepatology. 2012; 55(6):1652-61. PMC: 4586034. DOI: 10.1002/hep.25556. View

Ly K, Xing J, Klevens R, Jiles R, Ward J, Holmberg S . The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med. 2012; 156(4):271-8. DOI: 10.7326/0003-4819-156-4-201202210-00004. View

Smith B, Morgan R, Beckett G, Falck-Ytter Y, Holtzman D, Teo C . Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep. 2012; 61(RR-4):1-32. View

Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2095-128. PMC: 10790329. DOI: 10.1016/S0140-6736(12)61728-0. View

Bruggmann P, Litwin A . Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit all. Clin Infect Dis. 2013; 57 Suppl 2:S56-61. PMC: 6279207. DOI: 10.1093/cid/cit271. View

Varan A, Mercer D, Stein M, Spaulding A . Hepatitis C seroprevalence among prison inmates since 2001: still high but declining. Public Health Rep. 2014; 129(2):187-95. PMC: 3904899. DOI: 10.1177/003335491412900213. View

10.

Razavi H, Waked I, Sarrazin C, Myers R, Idilman R, Calinas F . The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat. 2014; 21 Suppl 1:34-59. DOI: 10.1111/jvh.12248. View

11.

Pepin J, Abou Chakra C, Pepin E, Nault V, Valiquette L . Evolution of the global burden of viral infections from unsafe medical injections, 2000-2010. PLoS One. 2014; 9(6):e99677. PMC: 4049770. DOI: 10.1371/journal.pone.0099677. View

12.

Yehia B, Schranz A, Umscheid C, Lo Re 3rd V . The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis. PLoS One. 2014; 9(7):e101554. PMC: 4079454. DOI: 10.1371/journal.pone.0101554. View

13.

Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H . Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014; 61(1 Suppl):S45-57. DOI: 10.1016/j.jhep.2014.07.027. View

14.

Suryaprasad A, White J, Xu F, Eichler B, Hamilton J, Patel A . Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012. Clin Infect Dis. 2014; 59(10):1411-9. DOI: 10.1093/cid/ciu643. View

15.

Turner B, Taylor B, Hanson J, Liang Y, Veerapaneni P, Villarreal R . High priority for hepatitis C screening in safety net hospitals: Results from a prospective cohort of 4582 hospitalized baby boomers. Hepatology. 2015; 62(5):1388-95. DOI: 10.1002/hep.28018. View

16.

White D, Anderson E, Pfeil S, Trivedi T, Alter H . Results of a Rapid Hepatitis C Virus Screening and Diagnostic Testing Program in an Urban Emergency Department. Ann Emerg Med. 2015; 67(1):119-28. DOI: 10.1016/j.annemergmed.2015.06.023. View

17.

Greenaway C, Ma A, Kloda L, Klein M, Cnossen S, Schwarzer G . The Seroprevalence of Hepatitis C Antibodies in Immigrants and Refugees from Intermediate and High Endemic Countries: A Systematic Review and Meta-Analysis. PLoS One. 2015; 10(11):e0141715. PMC: 4641717. DOI: 10.1371/journal.pone.0141715. View

18.

He T, Li K, Roberts M, Spaulding A, Ayer T, Grefenstette J . Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons. Ann Intern Med. 2015; 164(2):84-92. PMC: 4854298. DOI: 10.7326/M15-0617. View

19.

Jonas M, Rodriguez C, Redd J, Sloane D, Winston B, Loftus B . Streamlining Screening to Treatment: The Hepatitis C Cascade of Care at Kaiser Permanente Mid-Atlantic States. Clin Infect Dis. 2016; 62(10):1290-1296. DOI: 10.1093/cid/ciw086. View

20.

Younossi Z, Park H, Henry L, Adeyemi A, Stepanova M . Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden. Gastroenterology. 2016; 150(7):1599-1608. DOI: 10.1053/j.gastro.2016.02.039. View